Evolution of Carbapenem-Resistant Serotype K1 Hypervirulent Klebsiella pneumoniae by Acquisition of blaVIM-1-Bearing Plasmid

Antimicrob Agents Chemother. 2019 Aug 23;63(9):e01056-19. doi: 10.1128/AAC.01056-19. Print 2019 Sep.

Abstract

We report the identification of a carbapenem-resistant, hypervirulent Klebsiella pneumoniae (hvKp) strain which produced the carbapenemase VIM-1. Genomic analysis showed that the strain belonged to sequence type ST23 and serotype K1, a major hvKp clone, and harbored three resistance-encoding plasmids. Among them, a blaVIM-1-bearing plasmid was found to possess a mosaic structure presumably generated by multiple gene mobilization events. This finding indicates that hvKp actively acquires mobile resistance-encoding elements, facilitating simultaneous expression of hypervirulence and carbapenem-resistance.

Keywords: Klebsiella pneumoniae; VIM; carbapenem resistance; hypervirulence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Proteins / genetics
  • Bacterial Proteins / metabolism
  • Carbapenems / therapeutic use*
  • Genome, Bacterial
  • Klebsiella Infections / drug therapy*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / pathogenicity*
  • Male
  • Mice
  • Multilocus Sequence Typing
  • Plasmids / genetics*
  • Serogroup
  • Virulence
  • Virulence Factors / genetics
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Carbapenems
  • Virulence Factors
  • beta-Lactamases
  • carbapenemase